Agentic AI Solutions, Associate Director
Eli Lilly and Company
Summary
The Agentic AI Solutions Lead is a hands-on, full-stack build role responsible for designing, building, and deploying AI-enabled workflows, agentic sourcing systems, and document-intelligence tools that help ESCO colleagues turn complex CDMO/CMO information into actionable sourcing decisions. This is a builder role, not an architecture-and-handoff role: the individual personally develops and ships working agents and applications, in partnership with Tech@Lilly and PRD Strategy where enterprise platforms and standards intersect.
Job description
Key Responsibilities
AI Solutions Engineering & Practical Tool Delivery
- Partner with ESCO sourcing operations leads and category managers to identify, prioritize, and scope high-value opportunities where agentic AI, machine learning, and automation can improve speed, productivity, insight generation, and decision quality across the CDMO/CMO network.
- Translate stakeholder needs into practical AI tools, technical designs, acceptance criteria, and delivery plans that fit real sourcing, supplier-management, and technical-transfer workflows.
- Build and deploy AI-enabled applications, services, and workflows that integrate models, sourcing data sources, document collections, and user-facing interfaces for decision support and workflow automation.
Agentic Sourcing AI Systems & Knowledge Extraction
- Create reusable agent skills, task harnesses, validators, run ledgers, and reproducibility controls that allow AI agents to execute diverse, long-running sourcing tasks reliably (e.g., capacity assessment, RFx analysis, technical-transfer status tracking).
- Build agentic knowledge extraction and question-answering systems for structured and unstructured sourcing content, including CDMO proposals, quality/audit reports, contracts, capacity data, technical-transfer records, and supplier scorecards.
- Design evaluation, monitoring, guardrails, and human-in-the-loop escalation patterns so agentic outputs are auditable, traceable, and appropriate for high-consequence sourcing and supply-continuity decisions.
- Apply knowledge graphs, data ontologies, and structured knowledge representation where they improve retrieval, traceability, and reuse across the supplier and CDMO network.
Decision Support & Workflow Transformation
- Build the PRD Supply Chain Intelligence (AI) agent end to end — from feasibility through pilot to production — as a core deliverable of this role, in coordination with Tech@Lilly and PRD Strategy's End-to-End Supply Chain Design Process.
- Turn information from CDMO/CMO documents, sourcing systems, and business processes into faster insights, stronger judgment, and improved ways of working across ESCO.
- Communicate model outputs, evidence, assumptions, limitations, uncertainty, and recommended actions through clear visualizations and decision-support outputs that influence solution adoption and sourcing decisions.
Reliability, Validation, MLOps & Responsible AI
- Champion software engineering best practices including version control, automated testing, CI/CD, containers, documentation, reproducibility, observability, and fit-for-purpose MLOps/agent-ops practices.
- Develop validation, monitoring, documentation, and model-risk approaches aligned with intended use, responsible AI principles, GxP awareness, and regulatory expectations where applicable to sourcing and supply-chain decisions.
- Leverage cloud infrastructure to develop, test, deploy, and scale agentic workflows, document-intelligence systems, and analytics applications supporting ESCO.
Cross-Functional Collaboration & Scientific/Business Translation
- Partner across ESCO, PRD Strategy, Procurement, PRD functional leaders (Drug Substance, Drug Product, Analytical, Packaging), and Tech@Lilly to align agentic tools with enterprise data and platform standards, including the Portfolio Intelligence Hub and the CS&D Supply Chain Control Tower.
- Coordinate with Tech@Lilly's formal CRO data exchange and digital workflow for CMC lab experiments so ESCO's agentic tools adopt existing digital exchange pathways rather than creating parallel ones.
- Translate complex AI findings into clear narratives and business cases that influence solution adoption, workflow redesign, and sourcing-team priorities.
Capability Building, External Leadership & Mentorship
- Advance ESCO's technology roadmap for practical agentic AI tools, document intelligence, and reusable knowledge systems, drawing on DDCS's Digital Transformation and Data Science team as a cross-org reference and collaboration partner.
- Share methods, reference patterns, and lessons learned that help ESCO embed agentic AI into everyday sourcing work.
- Mentor team members and partners on reliable agentic systems, responsible AI, and rigorous communication of model assumptions, uncertainty, and decision impact.
- Stay current with the fast-moving agentic AI and LLM landscape and bring new tools, frameworks, and techniques into ESCO's practice where they add real value.
First-Year Outcomes
By month 6: First agentic AI pilot (e.g., CDMO capacity or technical-transfer status assistant) live with named users; document-intelligence extraction pipeline operating over a defined CDMO/CMO document set; PRD Supply Chain Intelligence agent feasibility assessment complete with a go/no-go recommendation. By month 12: PRD Supply Chain Intelligence agent in production pilot with defined evaluation criteria and monitoring in place; at least one additional agentic workflow adopted into standard ESCO sourcing operations; reusable agent skills and evaluation framework established for future ESCO AI use cases.
Requirements
- Earned Master's degree in Computational/Computer Science, Machine Learning, Artificial Intelligence, Engineering, or closely related STEM quantitative field
- Minimum of 5 years of post-degree experience
- 2+ years of applied technical work building AI or machine learning solutions in Python/R
- Working knowledge of NumPy, pandas, PyTorch, scikit-learn, or related ecosystem
- 3+ years of expertise in strategic thinking, problem framing, and translating ambiguous business needs into tractable AI, modeling, or automation workflows
- Demonstrated ability to frame ambiguous sourcing or supply-chain business needs as tractable AI, modeling, or computational workflows
- Skill in communicating technical recommendations with clearly stated assumptions, uncertainty, and limitations to sourcing, procurement, and business audiences
Benefits
- 401(k) Matching
- Pension
- Vacation Benefits
- Medical, Dental & Vision
- Prescription Drug Benefits
- Flexible Spending Accounts
- Life Insurance
- Death Benefits
- Employee Assistance Program
- Fitness Benefits
- Employee Clubs & Activities
- Company Bonus
Company overview
Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical corporation headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company has grown into one of the world's most valuable pharmaceutical enterprises, with operations in approximately 125 countries. Lilly specializes in developing and manufacturing innovative medicines across multiple therapeutic areas, including diabetes, oncology, neuroscience, immunology, and cardiometabolic diseases. The company is renowned for its groundbreaking work in insulin production, having been the first to mass-produce insulin and later developing the first commercially available insulin product in the U.S. Lilly's current portfolio includes blockbuster medications such as Mounjaro and Zepbound (tirzepatide) for diabetes and obesity, Trulicity (dulaglutide) for type 2 diabetes, Verzenio (abemaciclib) for breast cancer, and Taltz (ixekizumab) for autoimmune conditions. With approximately 47,000 employees worldwide, Lilly maintains a strong commitment to research and development, investing heavily in scientific innovation to address some of the world's most significant health challenges. The company operates with a mission to make life better for people around the world through the discovery and delivery of innovative medicines.